Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches

BACKGROUND: Despite its success in treating specific anxiety disorders, the effect of exposure therapy is limited by problems with tolerability, treatment resistance, and fear relapse after initial response. The identification of novel drug targets facilitating fear extinction in clinically relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartori, Simone B., Maurer, Verena, Murphy, Conor, Schmuckermair, Claudia, Muigg, Patrick, Neumann, Inga D., Whittle, Nigel, Singewald, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926792/
https://www.ncbi.nlm.nih.gov/pubmed/26625894
http://dx.doi.org/10.1093/ijnp/pyv128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926792/
https://www.ncbi.nlm.nih.gov/pubmed/26625894
http://dx.doi.org/10.1093/ijnp/pyv128

Ejemplares similares